Compressus nets U.S. patent for medical message routing

Compressus has received a notice of allowance from the U.S. Patent & Trademark Office for its patent application, which represents the foundational medical message routing technologies that allow the Compressus MEDxConnect system to provide a virtualized workflow environment to healthcare providers.

The patent, entitled “Autonomous Routing of Network Messages Within a Healthcare Communication Networkf" covers MEDxConnect, which employs intelligent analysis based on the data received and required end user parameters to distribute the data in the appropriate context based on specific factors, according to the company.

Compressus of Washington, D.C., said that its MEDxConnect System acts as a communications hub, enabling various PACS, hospital information systems, RIS and other data information systems to connect and communicate, using HL7, DICOM and other standards.



Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”